Distribution
After intravenous administration, thallous chloride Tl 201 clears from the blood with maximal concentration in normal myocardium occurring at about 10 minutes. It will, in addition, localize in parathyroid adenomas; it is not specific since it will localize to a lesser extent in sites of parathyroid hyperplasia and other abnormal tissues such as thyroid adenoma, neoplasia (e.g., parathyroid carcinoma), and sarcoid. Biodistribution is generally proportional to organ blood flow at the time of injection. Blood clearance of thallous chloride Tl 201 is primarily by the myocardium, thyroid, liver, kidneys, and stomach with the remainder distributing fairly uniformly throughout the body. The dosimetry data in Table 1 reflect this distribution pattern and are based on a biological half-life of 2.4 days.
Elimination
Five minutes after intravenous administration only 5% to 8% of injected activity remained in the blood. A biexponential disappearance curve was obtained, with 91.5 % of the blood radioactivity disappearing with a half-time of about 5 minutes. The remainder had a half-time of about 40 hours.
Excretion
Approximately 4% to 8% of the injected dose was excreted in the urine in the first 24 hours. The whole body disappearance half-time was 9.8 ± 2.5 days. Kidney concentration was found to be about 3% of the injected activity and the testicular content was 0.15%. Net thyroid activity was determined to be only 0.2% of the injected dose, and the activity disappeared in 24 hours. From anterior and posterior whole-body scans, it was determined that about 45% of the injected dose was in the large intestines and contiguous structures (liver, kidneys, abdominal musculature).